Kenny S. Frazier
Nessuna posizione attualmente
Profilo
Kenny S.
Frazier held the position of Senior Director-Clinical Operations at Lexicon Pharmaceuticals, Inc. and the position of VP-Clinical Development & Regulatory Affairs at Opexa Therapeutics, Inc. He obtained an undergraduate degree from Texas Tech University.
Precedenti posizioni note di Kenny S. Frazier
| Società | Posizione | Fine |
|---|---|---|
Opexa Therapeutics, Inc.
 Opexa Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Opexa Therapeutics, Inc. engages as a biopharmaceutical company, which develops personalized immunotherapy with the potential to treat major illnesses including multiple sclerosis and other autoimmune diseases. Its product candidates include Tcelna and OPX-212. The company was founded in March 1991 and is headquartered in The Woodlands, TX. | Direttore Tecnico/Scientifico/R&S | - |
| LEXICON PHARMACEUTICALS, INC. | Direttore Tecnico/Scientifico/R&S | 13/09/2012 |
Formazione di Kenny S. Frazier
| Texas Tech University | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| LEXICON PHARMACEUTICALS, INC. | Health Technology |
| Aziende private | 1 |
|---|---|
Opexa Therapeutics, Inc.
Opexa Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Opexa Therapeutics, Inc. engages as a biopharmaceutical company, which develops personalized immunotherapy with the potential to treat major illnesses including multiple sclerosis and other autoimmune diseases. Its product candidates include Tcelna and OPX-212. The company was founded in March 1991 and is headquartered in The Woodlands, TX. | Health Technology |
- Borsa valori
- Insiders
- Kenny S. Frazier
